HC Wainwright & Co. Reiterates Buy on Adicet Bio, Maintains $27 Price Target

9/18/2026
Impact: 75
Healthcare

HC Wainwright & Co. analyst Robert Burns has reiterated a Buy rating on Adicet Bio (NASDAQ: ACET) and has maintained a price target of $27 for the stock.

AI summary, not financial advice

Share: